About
Drug Reformulations
Areas of Focus
Categories
Drug Delivery & FormulationChina
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
8
As Collaborator
0
Total Enrollment
1,458
By Phase
PHASE1: 3PHASE3: 3PHASE2: 1PHASE1/PHASE2: 1
By Status
COMPLETED: 6ENROLLING_BY_INVITATION: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06744569Lead Sponsor
A Phase I Clinical Trial to Evaluate CU-10101 Unguent
PHASE1Enrolling by invitation
64 participants
Started: Sep 12, 2024 · Completed: Sep 9, 2025
NCT06585696Lead Sponsor
A Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type a for Injection (CU-20101)
PHASE3Active, not recruiting
554 participants
Started: Jun 11, 2024 · Completed: May 1, 2026
NCT06194188Lead Sponsor
A Phase 2 Clinical Study of CU-20401
PHASE2Completed
108 participants
Started: Dec 20, 2023 · Completed: Sep 2, 2024
NCT05793892Lead Sponsor
Efficacy and Safety of Lidocaine and Tetracaine Cream for Facial Laser Aesthetics in Chinese Adults
PHASE3Completed
286 participants
Started: Apr 6, 2023 · Completed: Oct 25, 2023
NCT05380427Lead Sponsor
A Phase I Clinical Trial Evaluating the Safety, Tolerability, and Pharmacokinetics of CU-40101 Liniment in Single and Multiple Doses in Adult Male Androgenic Alopecia Subjects
PHASE1Completed
80 participants
Started: Aug 15, 2022 · Completed: Feb 22, 2024
Locations (1)
Headquarters
Shanghai, China
Map
Loading map...